{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:11:12Z","timestamp":1790683872818,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"am","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jamda.2020.02.019","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T07:40:25Z","timestamp":1586763625000},"page":"830-836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Benzodiazepine Dispensing to Persons With Dementia in France, 2011-2016: A Nationwide Study"],"prefix":"10.1016","volume":"21","author":[{"given":"Ana\u00efs","family":"Couret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Gallini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Poncet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Renoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryse","family":"Lapeyre-Mestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Gardette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2020.02.019_bib2","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/S0140-6736(16)32457-6","article-title":"Alzheimer's disease: Expedition into the unknown","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2020.02.019_bib3","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.jamda.2020.02.019_bib4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/1039856218766123","article-title":"Alzheimer disease: Non-pharmacological and pharmacological management of cognition and neuropsychiatric symptoms","volume":"26","author":"Loi","year":"2018","journal-title":"Australas Psychiatry"},{"key":"10.1016\/j.jamda.2020.02.019_bib5","series-title":"Maladie d'Alzheimer et Maladies Apparent\u00e9es: Prise En Charge Des Troubles Du Comportement Perturbateurs [Alzheimer's Disease and Related Dementias: Management of Behavioural and Psychological Symptoms of Dementia]","year":"2009"},{"key":"10.1016\/j.jamda.2020.02.019_bib6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for potentially inappropriate medication Use in older adults","volume":"67","year":"2019","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2020.02.019_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: Version 2","volume":"44","author":"O'Mahony","year":"2015","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2020.02.019_bib8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00228-007-0324-2","article-title":"Potentially inappropriate medications in the elderly: A French consensus panel list","volume":"63","author":"Laroche","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2020.02.019_bib9","series-title":"Benzodiaz\u00e9pine \u00e0 Demi Vie Longue Chez Le Sujet \u00c2g\u00e9 [Long Half Life Benzodiazepine in the Elderly]","year":"2012"},{"key":"10.1016\/j.jamda.2020.02.019_bib10","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jalz.2015.10.006","article-title":"Benzodiazepine, psychotropic medication, and dementia: A population-based cohort study","volume":"12","author":"Shash","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jamda.2020.02.019_bib11","series-title":"Etat des lieux de la consommation des benzodiaz\u00e9pines en France [Overview of benzodiazepine use in France]","year":"2017"},{"key":"10.1016\/j.jamda.2020.02.019_bib12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/pds.4123","article-title":"Trends in incident use of benzodiazepines and Z-drugs in France from 2006 to 2012: A population-based study","volume":"26","author":"B\u00e9nard-Laribi\u00e8re","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jamda.2020.02.019_bib13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1017\/S1041610214001975","article-title":"Trends in use of psychotropic medications among patients treated with cholinesterase inhibitors in Japan from 2002 to 2010","volume":"27","author":"Okumura","year":"2015","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2020.02.019_bib14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.archger.2015.01.020","article-title":"Pharmaceutical consumption and cost in patients with dementia: A longitudinal study by the Registry of Dementias of Girona (ReDeGi) in Catalonia (Spain)","volume":"60","author":"Turr\u00f3-Garriga","year":"2015","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.jamda.2020.02.019_bib15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40266-016-0380-3","article-title":"Changing pattern of sedative use in\u00a0older adults: A population-based cohort study","volume":"33","author":"Iaboni","year":"2016","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2020.02.019_bib16","doi-asserted-by":"crossref","first-page":"e6231","DOI":"10.1136\/bmj.e6231","article-title":"Benzodiazepine use and risk of dementia: Prospective population based study","volume":"345","author":"Billioti de Gage","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2020.02.019_bib17","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer's disease: Case-control study","volume":"349","author":"Billioti de Gage","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2020.02.019_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40263-015-0305-4","article-title":"The benzodiazepine-dementia disorders link: Current state of knowledge","volume":"30","author":"Pariente","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jamda.2020.02.019_bib19","series-title":"Arr\u00eat Des Benzodiaz\u00e9pines et M\u00e9dicaments Apparent\u00e9s: D\u00e9marche Du M\u00e9decin Traitant En Ambulatoire [Benzodiazepines and related drugs discontinuation: procedure of the primary care physician]","year":"2015"},{"key":"10.1016\/j.jamda.2020.02.019_bib20","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: From the syst\u00e8me national d'information interr\u00e9gimes de l'Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.jamda.2020.02.019_bib21","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/pds.4233","article-title":"The National Healthcare System claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology","volume":"26","author":"Bezin","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jamda.2020.02.019_bib22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.revmed.2014.11.009","article-title":"French health insurance databases: What interest for medical research?","volume":"36","author":"Moulis","year":"2015","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jamda.2020.02.019_bib23","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1016\/j.respe.2017.01.115","volume":"65","author":"Gallini","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.jamda.2020.02.019_bib24","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/fcp.12214","article-title":"Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies","volume":"30","author":"Palmaro","year":"2016","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jamda.2020.02.019_bib27","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/pds.4193","article-title":"Immeasurable time bias due to hospitalization in medico-administrative databases: Which impact for pharmacoepidemiological studies?","volume":"26","author":"Palmaro","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jamda.2020.02.019_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2458-9-33","article-title":"Ecological association between a deprivation index and mortality in France over the period 1997-2001: Variations with spatial scale, degree of urbanicity, age, gender and cause of death","volume":"9","author":"Rey","year":"2009","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jamda.2020.02.019_bib29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.jamda.2020.02.019_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002080","article-title":"Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: A cohort study","volume":"3","author":"Martinez","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.jamda.2020.02.019_bib31","article-title":"Misuse of benzodiazepines in France","volume":"2","author":"Micallef","year":"2016"},{"key":"10.1016\/j.jamda.2020.02.019_bib32","series-title":"La Situation Des EHPAD En 2016 [Nursing Homes' situation in 2016]","year":"2017"},{"key":"10.1016\/j.jamda.2020.02.019_bib33","series-title":"La Situation Des EHPAD En 2017 [Nursing Homes' situation in 2017]","year":"2019"},{"key":"10.1016\/j.jamda.2020.02.019_bib34","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.euroneuro.2014.10.004","article-title":"High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort","volume":"24","author":"Taipale","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jamda.2020.02.019_bib35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0897190015579451","article-title":"Impact of FDA black box warning on psychotropic drug use in noninstitutionalized elderly patients diagnosed with dementia: A retrospective study","volume":"29","author":"Singh","year":"2016","journal-title":"J\u00a0Pharm Pract"},{"key":"10.1016\/j.jamda.2020.02.019_bib36","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s11096-016-0318-1","article-title":"Improvements in the prescribing of antipsychotics in dementia and psychogeriatric units in New Zealand","volume":"38","author":"Tordoff","year":"2016","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.jamda.2020.02.019_bib37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1017\/S1041610217001788","article-title":"Change in psychotropic drug use in Norwegian nursing homes between 2004 and 2011","volume":"30","author":"Selb\u00e6k","year":"2018","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2020.02.019_bib38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/2050-6511-14-56","article-title":"Psychotropic drug use among people with dementia\u2014a six-month follow-up study","volume":"14","author":"Gustafsson","year":"2013","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.jamda.2020.02.019_bib39","doi-asserted-by":"crossref","first-page":"e0173450","DOI":"10.1371\/journal.pone.0173450","article-title":"Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011","volume":"12","author":"Tolppanen","year":"2017","journal-title":"PLoS One"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861020302152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861020302152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:21:00Z","timestamp":1761506460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861020302152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1525861020302152"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2020.02.019","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzodiazepine Dispensing to Persons With Dementia in France, 2011-2016: A Nationwide Study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2020.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}